克服障碍:硬膜外麻醉创始人Fidel Pagés逝世百年后的遗产
百年来硬膜外麻醉历经传播障碍与技术革新,现广泛用于产科和慢性疼痛医学,但仍面临手术室效率压力和低失败容忍度的现代挑战。
要点
- 硬膜外麻醉最初报告未获广泛阅读和认可,传播面临障碍。
- 如今硬膜外麻醉广泛用于产科和慢性疼痛医学,但手术室效率压力构成现代挑战。
核心结论
- 硬膜外麻醉自Pagés首次描述后历经百年发展,虽面临传播与临床挑战,仍成为重要麻醉技术。
研究设计与样本
- 本文为历史回顾性文章, revisiting Pagés原始报告并总结关键创新。
主要发现
- Pagés于1923年去世,年仅37岁。
- 最初报告未获广泛阅读和认可,但技术优点推动了后续创新。
- 目前硬膜外麻醉广泛用于产科和慢性疼痛医学。
临床怎么用
- 硬膜外麻醉可用于产科和慢性疼痛医学,但需应对手术室效率压力和低失败容忍度的挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Fidel Pagés, a Spanish surgeon, tragically died in 1923 at the age of 37, just 2 years after his publication "Anestesia Metamérica," the first description of human thoracolumbar epidural anesthesia. In the intervening 100 years, epidural anesthesia has faced countless obstacles, starting with the dissemination of his initial report, which was not widely read nor appreciated at the time. However, the merits of the technique have fueled innovations to meet these challenges over the years. Even today, while epidural anesthesia is widely embraced, particularly in obstetric and chronic pain medicine, the pressures of the operating room for efficiency and a low tolerance for failure, pose modern-day challenges. Here, we revisit Pagés' original report and highlight the key innovations that have allowed for the evolution of this essential anesthesia technique.
引用
- Chinn GA, Gray AT, Larson MD, et al. Overcoming Obstacles: The Legacy of Fidel Pagés, Founder of the Epidural, 100 Years After His Passing. Anesth Analg. 2023. PMID: 38048631. doi:10.1213/ANE.0000000000006706
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。